Bayer relocates UK diagnostics division:
This article was originally published in Clinica
Bayer's UK subsidiary has relocated its diagnostics division to corporate headquarters in Newbury, Berkshire, already home to Bayer's self-medication and pharmaceutical businesses. Bayer Diagnostics, which produces clinical diagnostic equipment and a range of products to test for diabetes, has around 90 employees.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.